Intercell
Latest round
- Series C
Last raised
- Nov 2003
Total raised
- $81M
Investors
- 11
About Intercell
Intercell AG is based in Austria and engages in development, research and commercialization of novel vaccines and monoclonal antibodies for the prevention and treatment of infectious diseases.
Who invested in Intercell
11 investors across 4 rounds
See all investors in Intercell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Intercell
Who invested in Intercell?
Intercell has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intercell raised?
Intercell has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Intercell last raise money?
Intercell's most recent round on record is a Series C, in Nov 2003.
What does Intercell do?
Intercell AG is based in Austria and engages in development, research and commercialization of novel vaccines and monoclonal antibodies for the prevention and treatment of infectious diseases.
Where is Intercell headquartered?
Intercell is headquartered in Vienna, Austria.
Which VCs invest in companies like Intercell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Intercell's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Intercell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.